ATP13A3 and neuroblastoma: Our data thus provide compelling evidence that AMXT 1501 effectively targets ATP13A3‐mediated polyamine uptake in neuroblastoma cells, underscoring the therapeutic promise of ATP13A3 targeting in neuroblastoma.